SI-BONE, Inc. (SIBN)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 48,630 | 47,290 | 40,340 | 39,969 |
| Cost of goods sold | 9,823 | 9,595 | 8,437 | 8,393 |
| Gross profit | 38,807 | 37,695 | 31,903 | 31,576 |
| Sales and marketing | 30,781 | 30,681 | 27,448 | 28,970 |
| Research and development | 4,309 | 4,534 | 3,993 | 4,352 |
| General and administrative | 10,721 | 9,960 | 8,095 | 8,332 |
| Total operating expenses | 45,811 | 45,175 | 39,536 | 41,654 |
| Loss from operations | -7,004 | -7,480 | -7,633 | -10,078 |
| Interest income | 1,520 | 1,592 | 1,936 | 2,015 |
| Interest expense | 666 | 662 | 884 | 880 |
| Other income (expense) | -2 | 8 | 6 | 4 |
| Net loss | -6,152 | -6,542 | -6,575 | -8,939 |
| Unrealized loss on marketable securities | -29 | -81 | 216 | -8 |
| Changes in foreign currency translation | 369 | 157 | 139 | -31 |
| Comprehensive loss | -5,812 | -6,466 | -6,220 | -8,978 |
| Net loss per share, basic (in dollars per share) | -0.14 | -0.15 | -0.16 | -0.22 |
| Net loss per share, diluted (in dollars per share) | -0.14 | -0.15 | -0.16 | -0.22 |
| Weighted-average number of common shares used to compute basic net loss per share (in shares) | 42,788,123 | 42,337,481 | 41,717,505 | 41,317,627 |
| Weighted-average number of common shares used to compute diluted net loss per share (in shares) | 42,788,123 | 42,337,481 | 41,717,505 | 41,317,627 |